These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1848960)

  • 1. Mouse protection test as a predictor of the protective capacity of synthetic foot-and-mouth disease vaccines.
    Mulcahy G; Pullen LA; Gale C; DiMarchi RD; Doel TR
    Vaccine; 1991 Jan; 9(1):19-24. PubMed ID: 1848960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus.
    Mulcahy G; Gale C; Robertson P; Iyisan S; DiMarchi RD; Doel TR
    Vaccine; 1990 Jun; 8(3):249-56. PubMed ID: 2163575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maturation of functional antibody affinity in animals immunised with synthetic foot-and-mouth disease virus.
    Mulcahy G; Reid E; Dimarchi RD; Gale C; Doel TR
    Res Vet Sci; 1992 Mar; 52(2):133-40. PubMed ID: 1316628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs.
    Mayr GA; O'Donnell V; Chinsangaram J; Mason PW; Grubman MJ
    Vaccine; 2001 Feb; 19(15-16):2152-62. PubMed ID: 11228388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
    Dunn CS; Samuel AR; Pullen LA; Anderson J
    Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between in vitro neutralization titres and in vivo protection against homologous and heterologous challenge induced by vaccines prepared from two serologically distinct variants of foot-and-mouth disease virus, serotype A22.
    Bolwell C; Parry NR; Rowlands DJ
    J Gen Virol; 1992 Mar; 73 ( Pt 3)():727-31. PubMed ID: 1312129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale use of liquid-phase blocking sandwich ELISA for the evaluation of protective immunity against aphthovirus in cattle vaccinated with oil-adjuvanted vaccines in Argentina.
    Periolo OH; Seki C; Grigera PR; Robiolo B; Fernández G; Maradei E; D'Aloia R; La Torre JL
    Vaccine; 1993; 11(7):754-60. PubMed ID: 8393607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the anti-FMD virus antibody reaction as measured by different assays, and protection in vivo against challenge infection.
    McCullough KC; Bruckner L; Schaffner R; Fraefel W; Müller HK; Kihm U
    Vet Microbiol; 1992 Feb; 30(2-3):99-112. PubMed ID: 1313624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of monoclonal antibodies to quality control of foot-and-mouth disease vaccines.
    Alonso A; Darsie GC; Teixeira AC; Reis JL; Mesquita JA
    Vaccine; 1994 Jun; 12(8):682-6. PubMed ID: 8091844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total and isotype humoral responses in cattle vaccinated with foot and mouth disease virus (FMDV) immunogen produced either in bovine tongue tissue or in BHK-21 cell suspension cultures.
    Capozzo AV; Periolo OH; Robiolo B; Seki C; La Torre JL; Grigera PR
    Vaccine; 1997; 15(6-7):624-30. PubMed ID: 9178462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies elicited by a biosynthetic peptide related to a major immunogenic area of FMDV A12.
    Borca MV; Moore DM; Srikumaran S; Morgan DO
    Viral Immunol; 1990; 3(2):147-60. PubMed ID: 1694429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between virus neutralization and serum protection bioassays for IgG and IgM antibodies to foot-and-mouth disease virus.
    Trautman R; Bennett CE
    J Gen Virol; 1979 Mar; 42(3):457-66. PubMed ID: 219135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between serum antibody titres and protection from foot and mouth disease in pigs after oil emulsion vaccination.
    Black L; Francis MJ; Rweyemamu MM; Umebara O; Boge A
    J Biol Stand; 1984 Oct; 12(4):379-89. PubMed ID: 6098583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
    Barrera J; Brake DA; Schutta C; Ettyreddy D; Kamicker BJ; Rasmussen MV; Bravo de Rueda C; Zurita M; Pisano M; Hurtle W; Brough DE; Butman BT; Harper BG; Neilan JG
    Vaccine; 2018 Nov; 36(48):7345-7352. PubMed ID: 30327212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge.
    Maree FF; Nsamba P; Mutowembwa P; Rotherham LS; Esterhuysen J; Scott K
    Vaccine; 2015 Jun; 33(25):2909-16. PubMed ID: 25930116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus.
    Doel TR; Gale C; Do Amaral CM; Mulcahy G; Dimarchi R
    J Virol; 1990 May; 64(5):2260-4. PubMed ID: 2157884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive immunization of guinea pigs with llama single-domain antibody fragments against foot-and-mouth disease.
    Harmsen MM; van Solt CB; Fijten HP; van Keulen L; Rosalia RA; Weerdmeester K; Cornelissen AH; De Bruin MG; Eblé PL; Dekker A
    Vet Microbiol; 2007 Mar; 120(3-4):193-206. PubMed ID: 17127019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic virus expressing the FMDV structural protein VP1.
    Wigdorovitz A; Pérez Filgueira DM; Robertson N; Carrillo C; Sadir AM; Morris TJ; Borca MV
    Virology; 1999 Nov; 264(1):85-91. PubMed ID: 10544132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of foot-and-mouth disease virus-neutralizing idiotypes from immune bovine and swine with anti-murine idiotype antibody probes.
    Garmendia AE; Borca MV; Morgan DO; Baxt B
    J Immunol; 1989 Nov; 143(9):3015-9. PubMed ID: 2553817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative and quantitative differences in the immune response to foot-and-mouth disease virus antigens and synthetic peptides.
    Francis MJ; Fry CM; Rowlands DJ; Brown F
    J Gen Virol; 1988 Oct; 69 ( Pt 10)():2483-91. PubMed ID: 2844964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.